During the past decade, Manitoba Prostate Centre conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Manitoba Prostate Centre" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 3 trials as a collaborator and "Ferring Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Manitoba Prostate Centre" are "Prostate Cancer" (3 trials), "Cancer of the Prostate" (2 trials), "Chronic Prostatitis With Chronic Pelvic Pain Syndrome" (1 trials), "Hormone Sensitive Prostate Cancer" (1 trials) and "Nonmetastatic Castration-Resistant Prostate Cancer" (1 trials). Many other conditions were trialed in "Manitoba Prostate Centre" in a lesser frequency.

Most popular intervention types in "Manitoba Prostate Centre" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Enzalutamide" (3 trials), "Leuprolide" (1 trials), "Tanezumab" (1 trials) and "degarelix" (1 trials). Other intervention names were less common.

The vast majority of trials in "Manitoba Prostate Centre" are 5 trials for "Male" genders.

Currently, there are NaN active trials in "Manitoba Prostate Centre". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Manitoba Prostate Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Manitoba Prostate Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".